Belinda D Jackson1, Kathleen Gray2, Simon R Knowles3, Peter De Cruz4. 1. Department of Gastroenterology, The Austin Hospital, Melbourne Australia Department of Medicine, University of Melbourne, Austin Academic Centre, Melbourne, Australia. 2. Health and Biomedical Informatics Centre (HABIC), University of Melbourne, Melbourne, Australia. 3. Faculty of Health, Arts and Design, Swinburne University of Technology, Melbourne, Australia Department of Mental Health, St Vincent's Hospital, Melbourne, Australia Department of Psychiatry, The University of Melbourne, Melbourne, Australia Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Australia. 4. Department of Gastroenterology, The Austin Hospital, Melbourne Australia Department of Medicine, University of Melbourne, Austin Academic Centre, Melbourne, Australia ppdecruz@gmail.com.
Abstract
BACKGROUND AND AIMS: Electronic-health technologies (eHealth) such as Web-based interventions, virtual clinics, smart-phone applications, and telemedicine are being used to manage patients with inflammatory bowel disease (IBD). We aimed to: (1) Evaluate the impact of eHealth technologies on conventional clinical indices and patient-reported outcome measures (PROs) in IBD; (2) assess the effectiveness, cost-effectiveness and feasibility of using eHealth technologies to facilitate the self-management of individuals with IBD, and; (3) provide recommendations for their design and optimal use for patient care. METHODS: Relevant publications were identified via a literature search, and 17 publications were selected based on predefined quality parameters. RESULTS: Six randomized controlled trials and nine observational studies utilizing eHealth technologies in IBD were identified. Compared with standard outpatient-led care, eHealth technologies have led to improvements in: Relapse duration [(n = 1) 18 days vs 77 days, p < 0.001]; disease activity (n = 2); short-term medication adherence (n = 3); quality of life (n = 4); IBD knowledge (n = 2); healthcare costs (n = 4); the number of acute visits to the outpatient clinic due to IBD symptoms (n = 1), and; facilitating the remote management of up to 20% of an IBD cohort (n = 2). Methodological shortcomings of eHealth studies include heterogeneity of outcome measures, lack of clinician/patient input, lack of validation against conventional clinical indices and PROs, and limited cost-benefit analyses. CONCLUSIONS: EHealth technologies have the potential for promoting self-management and reducing the impact of the growing burden of IBD on health care resource utilization. A theoretical framework should be applied to the development, implementation, and evaluation of eHealth interventions.
BACKGROUND AND AIMS: Electronic-health technologies (eHealth) such as Web-based interventions, virtual clinics, smart-phone applications, and telemedicine are being used to manage patients with inflammatory bowel disease (IBD). We aimed to: (1) Evaluate the impact of eHealth technologies on conventional clinical indices and patient-reported outcome measures (PROs) in IBD; (2) assess the effectiveness, cost-effectiveness and feasibility of using eHealth technologies to facilitate the self-management of individuals with IBD, and; (3) provide recommendations for their design and optimal use for patient care. METHODS: Relevant publications were identified via a literature search, and 17 publications were selected based on predefined quality parameters. RESULTS: Six randomized controlled trials and nine observational studies utilizing eHealth technologies in IBD were identified. Compared with standard outpatient-led care, eHealth technologies have led to improvements in: Relapse duration [(n = 1) 18 days vs 77 days, p < 0.001]; disease activity (n = 2); short-term medication adherence (n = 3); quality of life (n = 4); IBD knowledge (n = 2); healthcare costs (n = 4); the number of acute visits to the outpatient clinic due to IBD symptoms (n = 1), and; facilitating the remote management of up to 20% of an IBD cohort (n = 2). Methodological shortcomings of eHealth studies include heterogeneity of outcome measures, lack of clinician/patient input, lack of validation against conventional clinical indices and PROs, and limited cost-benefit analyses. CONCLUSIONS: EHealth technologies have the potential for promoting self-management and reducing the impact of the growing burden of IBD on health care resource utilization. A theoretical framework should be applied to the development, implementation, and evaluation of eHealth interventions.
Authors: G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi Journal: Tech Coloproctol Date: 2020-01-25 Impact factor: 3.781
Authors: Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne Journal: Gut Date: 2019-09-27 Impact factor: 23.059
Authors: Javier Del Hoyo; Mariam Aguas; Pilar Nos; Guillermo Bastida; Raquel Faubel; Diana Muñoz; Alejandro Garrido-Marín; Elena Valero-Pérez; Sergio Bejar-Serrano Journal: J Med Internet Res Date: 2019-09-13 Impact factor: 5.428
Authors: Charlene Connolly Quinn; Sarah Chard; Katharine M Russman; Raymond K Cross; Erin G Roth; J Kevin Eckert Journal: J Med Internet Res Date: 2019-06-03 Impact factor: 5.428
Authors: Hongxia Shen; Rianne M J J van der Kleij; Paul J M van der Boog; Xinwei Chang; Niels H Chavannes Journal: J Med Internet Res Date: 2019-11-05 Impact factor: 5.428
Authors: Anna L Roberts; Abigail Fisher; Lee Smith; Malgorzata Heinrich; Henry W W Potts Journal: J Cancer Surviv Date: 2017-08-04 Impact factor: 4.442